2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Hypertrophic Olivary Degeneration

G. Moreno, K. Ng, A. Duffy (Sacramento, CA, USA)
Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease

I. Navalpotro-Gomez, A. Botas-Peñín, F. Molinet-Dronda, C. Gasca-Salas, M. Carmona-Abellán, H. Jiménez-Urbieta, M. Delgado-Alvarado, A. Quiroga-Varela, B. Gago, M.C. Rodríguez-Oroz (San Sebastian, Spain)
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC): a Mexican case report.

A. Kleinert-Altamirano, J. Patricio-Villagran, M. Fiesco-Roa, M. Gutierrez-Arriola (Tuxtla Gutierrez, Mexico)
Identification of a trehalose treatment regimen with potential to be translated into a therapeutic for the treatment of Parkinson’s disease

J. Koprich, P. Howson, T. Johnston, M. Hill, P. Ravenscroft, J. Brotchie (Toronto, ON, Canada)
Identification of the optimal carbidopa concentration in subcutaneously administered ND0612

L. Adar, T. Rachmilewitz Minei, S. Oren (Rehovot, Israel)
Idiopathic acquired sporadic (non-wilsonian) Hepatocerebral degeneration

S. Desai, P. Thakkar, S. Seth, b. vaishnav, P. Buch, J. Mannari (Anand, India)
IGF-1 levels are associated with CSF pathology and executive dysfunction in de novo Parkinson’s disease patients

G. Dervenoulas, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)
Imaging of phosphodiesterase 10 A (PDE10A) enzyme levels in the living human brain of Huntington’s disease gene expansion carriers and healthy controls with positron emission tomography.

P. Fazio, C. Fittzer-Attas, J. Bronzova, S. Nag, J. Warner, B. Landwehrmeyer, N. Al-Tawil, C. Halldin, L. Mrzljak, C. Sampaio, A. Varrone (Stockholm, Sweden)
Imbalance between dopaminergic and cholinergic neurotransmission following rotenone administration suggestive of Parkinson’s-like symptoms in male rats

S. Madiha, S. Haider (Karachi, Pakistan)
Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study

M. Amarandei (Bucharest, Romania)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z